Experienced in Lymphoid Hyperplasia

Dr. Destin R. Black

Gynecologic Oncology | Oncology
Wk Gynecologic Oncology Clinic
2600 Kings Hwy, Suite 420, 
Shreveport, LA 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Experienced in Lymphoid Hyperplasia
Wk Gynecologic Oncology Clinic
2600 Kings Hwy, Suite 420, 
Shreveport, LA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Destin Black is a Gynecologic Oncologist and an Oncologist in Shreveport, Louisiana. Dr. Black is rated as an Experienced provider by MediFind in the treatment of Lymphoid Hyperplasia. Her top areas of expertise are Endometrial Cancer, Vulvar Cancer, Ovarian Cancer, Splenectomy, and Hysterectomy. Dr. Black is currently accepting new patients.

Her clinical research consists of co-authoring 19 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Gynecologic Oncology
Oncology
Licenses
Obstetrics & Gynecology in LA
Hospital Affiliations
Willis Knighton Medical Center
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Louisiana Healthcare Connections
  • HMO
  • MANAGED MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

WK GYNECOLOGIC ONCOLOGY CLINIC
2600 Kings Hwy, Suite 420, Shreveport, LA 71103

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Randomized Controlled Trial of Robotic Versus Open Surgery for Early Stage Cervical Cancer (ROCC)
A Randomized Controlled Trial of Robotic Versus Open Surgery for Early Stage Cervical Cancer (ROCC)
Enrollment Status: Recruiting
Publish Date: December 19, 2024
Intervention Type: Other, Device
Study Phase: Not Applicable
A Randomized, Open-Label, Phase 3 Trial of Tisotumab Vedotin vs Investigator's Choice Chemotherapy in Second- or Third-Line Recurrent or Metastatic Cervical Cancer
A Randomized, Open-Label, Phase 3 Trial of Tisotumab Vedotin vs Investigator's Choice Chemotherapy in Second- or Third-Line Recurrent or Metastatic Cervical Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 15, 2025
Intervention Type: Drug
Study Drugs: Tisotumab Vedotin, Topotecan, Vinorelbine, Gemcitabine, Irinotecan, Pemetrexed
Study Phase: Phase 3
A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer (RUBY)
A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer (RUBY)
Enrollment Status: Active_not_recruiting
Publish Date: September 03, 2025
Intervention Type: Drug, Biological
Study Drugs: Dostarlimab, Carboplatin, Paclitaxel, Niraparib
Study Phase: Phase 3
MIRASOL: A Randomized, Open-label, Phase 3 Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression
MIRASOL: A Randomized, Open-label, Phase 3 Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression
Enrollment Status: Completed
Publish Date: August 27, 2025
Intervention Type: Drug
Study Drugs: Mirvetuximab Soravtansine, Paclitaxel, Topotecan, Pegylated liposomal doxorubicin
Study Phase: Phase 3
A Randomized, Double-blind, Phase 3 Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer
A Randomized, Double-blind, Phase 3 Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer
Enrollment Status: Active_not_recruiting
Publish Date: March 13, 2025
Intervention Type: Drug
Study Drugs: Niraparib, Dostarlimab
Study Phase: Phase 3
A Randomized Phase III Trial of Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab Versus Platinum Chemotherapy Plus Paclitaxel and Bevacizumab in Metastatic (Stage IVB), Persistent, or Recurrent Carcinoma of the Cervix
A Randomized Phase III Trial of Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab Versus Platinum Chemotherapy Plus Paclitaxel and Bevacizumab in Metastatic (Stage IVB), Persistent, or Recurrent Carcinoma of the Cervix
Enrollment Status: Active_not_recruiting
Publish Date: January 08, 2025
Intervention Type: Drug
Study Drugs: Bevacizumab, Cisplatin, Carboplatin, Paclitaxel, Atezolizumab
Study Phase: Phase 3
FORWARD I: A Randomized, Open Label Phase 3 Study to Evaluate the Safety and Efficacy of Mirvetuximab Soravtansine (IMGN853) Versus Investigator's Choice of Chemotherapy in Women With Folate Receptor Alpha Positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer
FORWARD I: A Randomized, Open Label Phase 3 Study to Evaluate the Safety and Efficacy of Mirvetuximab Soravtansine (IMGN853) Versus Investigator's Choice of Chemotherapy in Women With Folate Receptor Alpha Positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer
Enrollment Status: Completed
Publish Date: October 14, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 6 Less Clinical Trials

19 Total Publications

A plain language summary publication of patients' survival with endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel.
A plain language summary publication of patients' survival with endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel.
Journal: Therapeutic advances in medical oncology
Published: December 20, 2024
Similar Doctors
Experienced in Lymphoid Hyperplasia
Dr. Larry L. Frase
Oncology
Experienced in Lymphoid Hyperplasia
Dr. Larry L. Frase
Oncology

Texas Oncology PA

1300 N 4th St, 
Longview, TX 
 (55.4 miles away)
903-757-2122
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Larry Frase is an Oncologist in Longview, Texas. Dr. Frase is rated as an Advanced provider by MediFind in the treatment of Lymphoid Hyperplasia. His top areas of expertise are Paget Disease of the Breast, Myelodysplastic Syndrome (MDS), Breast Cancer, Melanoma, and Myringotomy. Dr. Frase is currently accepting new patients.

Experienced in Lymphoid Hyperplasia
Dr. Bassam Abi-Rached
Hematology Oncology | Hematology | Oncology
Experienced in Lymphoid Hyperplasia
Dr. Bassam Abi-Rached
Hematology Oncology | Hematology | Oncology

Christus Trinity Clinic

1453 E Bert Kouns Industrial Loop, 
Shreveport, LA 
 (5.3 miles away)
318-681-4138
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Bassam Abi-Rached is a Hematologist Oncology specialist and a Hematologist in Shreveport, Louisiana. Dr. Abi-Rached is rated as a Distinguished provider by MediFind in the treatment of Lymphoid Hyperplasia. His top areas of expertise are Thrombocytopenia, Adult Immune Thrombocytopenia, Hemangioma Thrombocytopenia Syndrome, Familial Colorectal Cancer, and Bone Marrow Aspiration. Dr. Abi-Rached is currently accepting new patients.

Experienced in Lymphoid Hyperplasia
Dr. Neelima Chintapalli
Hematology Oncology | Hematology | Oncology
Experienced in Lymphoid Hyperplasia
Dr. Neelima Chintapalli
Hematology Oncology | Hematology | Oncology

Christus Trinity Clinic

1453 E Bert Kouns Industrial Loop, Cancer Treatment Center, 
Shreveport, LA 
 (5.3 miles away)
318-681-4138
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Neelima Chintapalli is a Hematologist Oncology specialist and a Hematologist in Shreveport, Louisiana. Dr. Chintapalli is rated as a Distinguished provider by MediFind in the treatment of Lymphoid Hyperplasia. Her top areas of expertise are Pleuropulmonary Blastoma, Angiosarcoma, Breast Cancer, Lung Adenocarcinoma, and Bone Marrow Aspiration. Dr. Chintapalli is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Black's expertise for a condition
ConditionClose
View All 13 Distinguished Conditions
View All 9 Advanced Conditions
View All 43 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile